1. THU0143 Pharmacokinetics, Bioavailability and Safety of A Modified Release Once Daily Formulation of Tofacitinib in Healthy Volunteers. (10th June 2014) Authors: Lamba, M.; Wang, R.; Fletcher, T.; Alvey, C.; Hazra, A.; Kushner, J.; Larmann, J.; Stock, T. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 228 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. THU0188 Evaluation of Single-dose and Steady-State Pharmacokinetics, Bioavailability and Tolerability of the Modified Release Formulation of Tofacitinib vs the Immediate Release Formulation of Tofacitinib in Healthy Volunteers. (9th June 2015) Authors: Lamba, M.; Wang, R.; Fletcher, T.; Alvey, C.; Kushner, J.; Stock, T. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 262 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. THU0192 Evaluating Pharmacokinetic Predictors of Tofacitinib Clinical Response in Rheumatoid Arthritis. (15th July 2016) Authors: Lamba, M.; Furst, D.; Dikranian, A.; Dowty, M.; Hutmacher, M.; Conrado, D.; Stock, T.; Nduaka, C.; Krishnaswami, S. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 255 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗